Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT00585351
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older.
* Presumed Ischemic stroke or intracerebral hemorrhage within past 12 hours.
* NIH Stroke Scale (NIHSS) score \>/=1 point.
* Negative pregnancy test (females \< 50 years old).
* No pre-stroke disability (Rankin Scale Score 0-1).
* Patient evaluated for intravenous recombinant tissue Plasminogen Activator (rtPA) and intubation by the local physicians (if appropriate).
Exclusion Criteria:
* Onset of symptoms \> 12 hours or uncertain time of origin (if patient awakens with stroke, the time of onset will be the last time patient was normal).
* Reason for the transfer is to receive rtPA at the University of Iowa.
* Non-stroke etiology for symptoms.
* Temperature \> 37.8 C.
* Systolic blood pressure \< 100 mm Hg.
* Known allergy to ranitidine.
* White Blood Cell (WBC) \> 10K.
* Hemoglobin \< 9.0.
* Platelets \< 100,000.
* Glucose \< 60 or \> 300 mg/dl.
* Current need for antibiotics.
* Terminal illness with expected survival \< 3 months.
* Prison inmate or institutionalized individual.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00585351
Study Brief:
Protocol Section:
NCT00585351